We are very pleased to have completed our going public transaction by being quoted on the OTCMarkets OTC Pink Sheets as the first step to creating liquidity, particularly for our current and future shareholders.
Miami, FL (PRWEB) May 02, 2014
Soft Landing Labs, LTD. received notice that OTC Markets finished processing the Company's Annual Report for the year December 31, 2013, and it is now be quoted by the OTC Markets OTC Pink "Current Information" tier.
Shareholders of SLNZ are able to view the real-time Level II stock quotes for the Company’s common stock at http://www.otcmarkets.com/stock/SLNZ/quote
Dr. Abdel Fahmy, Chief Executive Officer of SLNZ, stated, “We are very pleased to have completed our going public transaction by being quoted on the OTCMarkets OTC Pink Sheets as the first step to creating liquidity, particularly for our current and future shareholders.”
About Soft Landing Labs, LTD
SLNZ was founded in 2009, to provide specialized laboratory testing focused on small molecules and toxicology including drug testing using highly sensitive technology.
Soft Landing Labs
747 Church Rd Ste F4
Elmhurst, IL 60126
Hamilton & Associates Securities Lawyers
Brenda Hamilton, Securities Attorney
101 Plaza Real South, Suite 202 N
Boca Raton, Florida 33432
Telephone: (561) 416-8956
Facsimile: (561) 416-2855
Investor Relations Contact:
EGM Firm, Inc.
1522 San Ignacio Unit # 3
Coral Gables, Florida 33143
Telephone: (800) 279-6650